IGF1R and cancer: Although IGF-1R and IR are both widely expressed on normal tissues, the strong implications of IGF-1R in various cancers have already been well recognized and therapeutic strategies with antibodies and small molecule TKIs have been actively tested in clinical trials [1, 2, 4, 37-39].